1-2 of 2
Francesca Mauro, MD
Close
Sort by
Journal Articles

External Validation On Biological Basis of New Prognostic Index in Early Asymptomatic Chronic Lymphocytic Leukemia (CLL) Patients: The Gruppo Italiano Studio Linfomi (GISL) Experience.

Stefano Molica, MD, Sonia Fabris, PhD, Giovanna Cutrona, PhD, Massimo Gentile, MD, Emanuela Anna Pesce, PhD, Francesco Di Raimondo, MD, Caterina Musolino, MD, Marco Gobbi, MD, Nicola Di Renzo, MD, Francesca Mauro, MD, Renato Cantaffa, MD, Maura Brugiatelli, MD, Francesco Merli, MD, Simonetta Zupo, PhD, Caterina Mammi, PhD, Luca Baldini, MD, Francesco Angrilli, MD, Gianni Quintana, MD, Ugo Consoli, MD, Giovanni Bertoldero, MD, Emilio Iannitto, MD, Paolo Di Tonno, MD, Antonio Fragasso, MD, Pellegrino Musto, MD, Maria Cristina Cox, MD, Gianluca Festini, PhD, Vincenzo Callea, MD, Stefano Sacchi, MD, Agostino Cortelezzi, MD, Giorgio Lambertenghi, MD, Robert Foà, MD, Antonino Neri, MD, Massimo Federico, MD, Manlio Ferrarini, MD, Fortunato Morabito, MD
Journal: Blood
Blood (2009) 114 (22): 2375.
https://doi.org/10.1182/blood.V114.22.2375.2375
Published: 2009
Journal Articles

What Have We Learned from Measuring Health-Related Quality of Life in Patients with Chronic Lymphocytic Leukemia? A Systematic Review of Published Studies from 1990 to 2007.

Stefano Molica, MD, Francesca Mauro, MD, Marco Vignetti, MD, Robin Foà, MD, Fabio Efficace, PhD
Journal: Blood
Blood (2007) 110 (11): 4718.
https://doi.org/10.1182/blood.V110.11.4718.4718
Published: 2007